ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 165 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,431 | -19.0% | 14,570 | 0.0% | 0.00% | – |
| Q1 2023 | $9,179 | -3.1% | 14,570 | -0.1% | 0.00% | – |
| Q4 2022 | $9,468 | -72.9% | 14,586 | -28.2% | 0.00% | – |
| Q3 2022 | $35,000 | +40.0% | 20,309 | -0.1% | 0.00% | – |
| Q2 2022 | $25,000 | +177.8% | 20,335 | +47.0% | 0.00% | – |
| Q1 2022 | $9,000 | -60.9% | 13,835 | -33.6% | 0.00% | – |
| Q4 2021 | $23,000 | -47.7% | 20,835 | -14.6% | 0.00% | – |
| Q3 2021 | $44,000 | -15.4% | 24,406 | +23.3% | 0.00% | – |
| Q2 2021 | $52,000 | -40.2% | 19,796 | -18.4% | 0.00% | – |
| Q1 2021 | $87,000 | +89.1% | 24,270 | +34.0% | 0.00% | – |
| Q4 2020 | $46,000 | 0.0% | 18,106 | -1.7% | 0.00% | – |
| Q3 2020 | $46,000 | -29.2% | 18,416 | -7.1% | 0.00% | – |
| Q2 2020 | $65,000 | +32.7% | 19,816 | 0.0% | 0.00% | – |
| Q1 2020 | $49,000 | -57.4% | 19,816 | -18.5% | 0.00% | – |
| Q4 2019 | $115,000 | -63.3% | 24,302 | -54.7% | 0.00% | -100.0% |
| Q2 2019 | $313,000 | +84.1% | 53,628 | +21.8% | 0.00% | 0.0% |
| Q1 2019 | $170,000 | +93.2% | 44,038 | -6.2% | 0.00% | – |
| Q4 2018 | $88,000 | -79.6% | 46,925 | -70.3% | 0.00% | -100.0% |
| Q2 2018 | $432,000 | -28.4% | 158,094 | -4.1% | 0.00% | -33.3% |
| Q1 2018 | $603,000 | -2.4% | 164,883 | +10.4% | 0.00% | -25.0% |
| Q4 2017 | $618,000 | -27.0% | 149,390 | +8.3% | 0.00% | -20.0% |
| Q3 2017 | $847,000 | +3.4% | 137,998 | +4.8% | 0.01% | -16.7% |
| Q2 2017 | $819,000 | -3.9% | 131,722 | -2.0% | 0.01% | 0.0% |
| Q1 2017 | $852,000 | +16.6% | 134,417 | -31.4% | 0.01% | 0.0% |
| Q4 2016 | $731,000 | -22.6% | 196,047 | -18.0% | 0.01% | -25.0% |
| Q3 2016 | $944,000 | -13.1% | 239,116 | -14.4% | 0.01% | -20.0% |
| Q2 2016 | $1,086,000 | -24.5% | 279,354 | +37.1% | 0.01% | -37.5% |
| Q1 2016 | $1,438,000 | -6.7% | 203,744 | +9.9% | 0.02% | -11.1% |
| Q4 2015 | $1,541,000 | +49.0% | 185,444 | +61.6% | 0.02% | +5.9% |
| Q3 2015 | $1,034,000 | – | 114,763 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |